Related Experiment Videos
Pulse glucocorticoid therapy. The 'big shot' revisited
1Service de Dermatologie, Hôpital Henri Mondor, Université Paris XII, Créteil, France.
Archives of Dermatology
|December 1, 1996
Summary
Pulse therapy involves high-dose intravenous glucocorticoids like methylprednisolone, administered over short periods. This treatment is often combined with lower-dose steroids or immunosuppressants for various medical conditions.
Area of Science:
- Pharmacology
- Clinical Medicine
Background:
- Pulse therapy utilizes high-dose, short-term intravenous infusions of glucocorticoids.
- Methylprednisolone and dexamethasone are commonly used in pulse therapy.
Discussion:
- Dosing for pulse therapy is variable, typically 10-20 mg/kg for methylprednisolone and 2-5 mg/kg for dexamethasone.
- These high doses, or 'megadoses,' are administered intravenously over 30 minutes to 1 hour, daily or every other day for 1-5 administrations.
- Equivalent doses: 500 mg methylprednisolone or 100 mg dexamethasone equals 625 mg prednisone.
Key Insights:
- Pulse glucocorticoid therapy is frequently combined with continuous low- or intermediate-dose glucocorticoids.
- Immunosuppressive agents are often used concurrently or subsequently to pulse therapy.
Outlook:
- Further research may standardize dosing and administration protocols.
- Investigating optimal combinations of pulse therapy with other agents could enhance treatment efficacy.